Therapeutic insights into incrasing HDL levels in Cardiovascular patients: Natural product Cucurbitacin I (JSI-124) increases HDL-C levels via up regulation of its target gene, 01/October/2014, 06.18 am

Therapeutic insights into incrasing HDL levels in Cardiovascular patients: Natural product Cucurbitacin I (JSI-124) increases HDL-C levels via up regulation of its target gene, 01/October/2014, 06.18 am

Therapeutic insights into incrasing HDL levels in Cardiovascular patients: Natural product Cucurbitacin I (JSI-124) increases HDL-C levels via up regulation of its target gene, 01/October/2014, 06.18 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Therapeutic insights into incrasing HDL levels in Cardiovascular patients: Natural product Cucurbitacin I (JSI-124)  increases HDL-C levels via up regulation of its target gene, 01/October/2014, 06.18 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that Cucurbitacin I (JSI-124), by increasing the expression of its target gene, it may increase HDL-C levels. Thereby, it may decrease the chances of developing cardiovascular disorders. Thus, this study suggests that pharmacological formulations encompassing “Cucurbitacin I (JSI-124) or its analogues may be used to increase HDL-C levels.